These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 5040665)

  • 1. Metabolism of amylobarbitone in patients with chronic liver disease.
    Mawer GE; Miller NE; Turnberg LA
    Br J Pharmacol; 1972 Mar; 44(3):549-60. PubMed ID: 5040665
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The kinetics of amylobarbitone metabolism in healthy men and women.
    Balasubramaniam K; Lucas SB; Mawer GE; Simons PJ
    Br J Pharmacol; 1970 Jul; 39(3):564-72. PubMed ID: 5472203
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impairment of cognitive function associated with hydroxyamylobarbitone accumulation in patients with renal insufficiency.
    Balasubramaniam K; Mawer GE; Pohl JE; Simons PJ
    Br J Pharmacol; 1972 Jun; 45(2):360-7. PubMed ID: 5048653
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The excretion of hydroxyamylobarbitone in man after oral administration of amylobarbitone and hydroxyamylobarbitone.
    Grove J; Toseland PA
    J Pharm Pharmacol; 1971 Dec; 23(12):936-40. PubMed ID: 4402019
    [No Abstract]   [Full Text] [Related]  

  • 5. Effect of paracetamol on amylobarbitone hydroxylation in man: a gas chromatographic method for simultaneous estimation of underivatized paracetamol and barbiturates.
    Kinsella HC; Smith S; Rogers HJ; Toseland PA
    J Pharm Pharmacol; 1979 Mar; 31(3):153-6. PubMed ID: 34688
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influence of pH on aggregation and protein binding of barbituric acid and amylobarbitone.
    Mikikits W; Skinner A; Spector RG; Watts DC
    Br J Pharmacol; 1971 Jan; 41(1):76-83. PubMed ID: 5547763
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Estimating the clearance of amylobarbitone from a single plasma measurement.
    Bachmann K
    Br J Clin Pharmacol; 1987 Jan; 23(1):94-8. PubMed ID: 3814466
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The prognostic value of the hydroxyamylobarbitone amylobarbitone ratio.
    Grove J; Toseland PA
    Arh Hig Rada Toksikol; 1970; 21(4):353-62. PubMed ID: 5525122
    [No Abstract]   [Full Text] [Related]  

  • 9. A multi-dose study on the human metabolism of amylobarbitone.
    Baldeo WC; Gilbert JN; Powell JW
    Xenobiotica; 1979 Apr; 9(4):205-8. PubMed ID: 483856
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum bile acid concentrations in patients with liver disease.
    Fausa O; Gjone E
    Scand J Gastroenterol; 1976; 11(5):537-43. PubMed ID: 959769
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A new look at biochemical tests of liver function.
    Miloszewski K; Walker BE; Hamilton M; Losowsky MS
    Rev Eur Etud Clin Biol; 1970 Oct; 15(8):878-81. PubMed ID: 5496773
    [No Abstract]   [Full Text] [Related]  

  • 12. The estimation of amylobarbitone and hydroxyamylobarbitone in serum by gas liquid chromatography.
    Balasubramaniam K; Mawer GE; Rodgers EM
    Br J Pharmacol; 1969 Oct; 37(2):546P-547P. PubMed ID: 5348459
    [No Abstract]   [Full Text] [Related]  

  • 13. [Liver in active hyperthyreosis].
    Meng W; Lorenz G; Eggert H; Meng S; Hampel R; Baufeld W
    Z Gesamte Inn Med; 1973 Dec; 28(24):787-91. PubMed ID: 4130587
    [No Abstract]   [Full Text] [Related]  

  • 14. The relationship between anthropometry and serum concentrations of alkaline phosphatase isoenzymes, liver-enzymes, albumin, and bilirubin.
    Ali AT; Paiker JE; Crowther NJ
    Am J Clin Pathol; 2006 Sep; 126(3):437-42. PubMed ID: 16880138
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differences in the rate of ethanol metabolism in recently drinking alcoholic and nondrinking subjects.
    Kater RM; Carulli N; Iber FL
    Am J Clin Nutr; 1969 Dec; 22(12):1608-17. PubMed ID: 5362487
    [No Abstract]   [Full Text] [Related]  

  • 16. [Liver function in choledochoduodenostomy following non-malignant biliary duct disorders].
    Keclík M; Huslarová A; Hyánek J
    Z Gastroenterol; 1972; 10(5):333-8. PubMed ID: 4667444
    [No Abstract]   [Full Text] [Related]  

  • 17. Hepatitis in the aged.
    Gibiński K; Fojt E; Suchan L
    Digestion; 1973; 8(3):254-60. PubMed ID: 4146513
    [No Abstract]   [Full Text] [Related]  

  • 18. Plasma concentrations of diazepam, noradiazepam and amylobarbitone after short-term treatment of anxious patients.
    Tansella M; Zimmermann Tansella C; Ferrario L; Preziati L; Tognoni G; Lader M
    Pharmakopsychiatr Neuropsychopharmakol; 1978 Mar; 11(2):68-75. PubMed ID: 347466
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thyrotrophin response to intravenous thyrotrophin-releasing hormone in patients with hepatic and renal disease.
    Pokroy N; Epstein S; Hendricks S; Pimstone B
    Horm Metab Res; 1974 Mar; 6(2):132-6. PubMed ID: 4208128
    [No Abstract]   [Full Text] [Related]  

  • 20. Corticosteroids in liver disease: studies on the biological conversion of prednisone to prednisolone and plasma protein binding.
    Powell LW; Axelsen E
    Gut; 1972 Sep; 13(9):690-6. PubMed ID: 4639403
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.